A LinkedIn post from Systole Health highlights an upcoming webinar focused on redesigning cardiology care for patients with cardiometabolic (CKM) conditions. According to the post, CEO Dr. Simin Gharib Lee is scheduled to host a discussion on April 8, 2026, with preventive cardiology leader Viet Le of Intermountain Health.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests the session will address how current cardiology clinic structures may be ill-suited to the growing CKM population and what an updated clinical model could look like. It also indicates a focus on how physician and advanced practice provider teams might expand capacity without increasing clinician burnout, and where technology can and cannot support this shift.
For investors, the content points to Systole Health’s strategic emphasis on care model innovation in cardiology rather than purely on technology deployment. By positioning itself in CKM care redesign and engaging health system leaders, the company may be seeking to deepen relationships with large provider organizations and potentially influence future demand for its solutions.
The educational framing aimed at cardiology service line and heart and vascular institute leaders could signal a business development strategy built around thought leadership. If the webinar translates into pilot projects or broader collaborations with health systems, it could improve Systole Health’s visibility and support long-term commercial opportunities in the cardiometabolic care segment.